Epipen Case Study

958 Words2 Pages

Entry 1: EpiPen’s pricing debacle and its impact on patients, insurers – Thea Singer http://www.northeastern.edu/news/2016/08/epipens-soaring-price-increase-and-rebate-and-what-both-mean-for-healthcare-economics-and-policy/

An EpiPen is a lifesaver for individuals who have anaphylactic or allergic reactions to materials because it provides a strong, respective dose of epinephrine to adults and children. In recent news, Mylan Inc has raised the price of EpiPens to a little of $600. At first glance, I thought that the motive behind this price hike was so increase the flow of revenues for the company. Many opponents of this price hike also have a similar view. They feel that this price hike is dangerous for consumers because there are no generic products similar to the EpiPen. This monopolistic approach has raised questions as to how drugs should be sold in America. In response to the negativity received because of their price jack, Mylan has announced a coupon system that may cover up to $300 of the cost of …show more content…

This article states that one of the initial factors that lead to this increase in premiums is at the hands of actuaries who did not accurately predict the types of customers that insurance providers were going to have. Furthermore, Weller states that this becomes a bigger problem because this increase in prices discourages healthy individuals from having insurance as it becomes very costly for them. As a result of healthy individuals dropping out of insurance pools, premiums again increase to cope for the sick patients, those that are major consumers of health insurance. As you can see, this cyclic process leads to a downwards spiral for many insurance companies as they begin to drop out of the markets in fear of losing more money. I feel that the only way to reduce premiums is to encourage the healthy population to rejoin the

Open Document